Little Green Pharma Ltd (LGP) Fair Value & Analysis
Healthcare · AU · Market cap A$73.0M
Fair value as of: Jun 26, 2026
Analysis
Little Green Pharma Ltd (LGP) currently trades at A$0.0640, while our model-based Fair Value estimate is A$0.0678 — implying the stock looks roughly 6.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Little Green Pharma Ltd produces and sells cannabis-based medicinal products across Australia and Europe. The company also provides infrastructure to support plant genetics programs and the development of its flower portfolio. It sells its products through a network of wholesalers, pharmacies, clinics, and GPs (general practitioners). The company was founded in 2016 and is based in Wembley, Australia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Little Green Pharma Ltd (LGP) undervalued?
What is the fair value of LGP?
What is the quality score of LGP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.